Navigation Links
CombinatoRx Provides Topline Results from Phase 2 RA Study with,CRx-139 and Very Low Dose Prednisolone

ACR 20 ACR 20 (Per (Intent To Protocol) Treat) ------------------------------------------------ ---------- ---------- CRx-102-002 CRx-102 63% 54% ------------------------------------------------ ---------- ---------- CRx-139-002 3mg prednisolone 36% 37% ------------------------------------------------ ---------- ----------

"This trial confirms that the strong clinical activity previously reported with CRx-102 should not be attributed to the effect of its low dose prednisolone component alone," said Alexis Borisy, President and CEO of CombinatoRx. "We are pleased to have this additional validation of our combination sciences approach to selective steroid amplification, and we look forward to rapidly advancing CRx-102 as our lead dissociated steroid combination for the treatment of RA and OA."

CRx-139 Misses Primary Endpoint, Shows Significance on Multiple Other Endpoints, Requires Further Analysis

While CRx-139 was not statistically significant vs. 3mg prednisolone as measured by ACR 20 at day 70, CRx-139 did achieve statistical significance vs. 3mg prednisolone alone as measured by ACR 20 and ACR 50 at earlier time points. Full analysis of the CRx-139 data is ongoing.

In this trial, CRx-139 was generally well tolerated and there were no drug-related serious adverse events reported for subjects treated with CRx-139. The most common adverse events observed with CRx-139 that occurred with a frequency of greater than 5% (9% or less) were headache and nausea, known side effects of paroxetine, one of the two components of CRx-139.

About the Trial Design

This trial was a multi-center, blinded, randomized study evaluating the effectiveness of two doses of CRx-1
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
2. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
3. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
4. CombinatoRx to Present Combination High Throughput Screening (cHTS) Data at Upcoming AACR Meeting
5. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
6. XTL Provides Update on Phase I Clinical Trial of XTL-2125
7. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
8. Daytrana (methylphenidate transdermal system) Provides Significant Effectiveness in ADHD Symptom Relief in Both Boys and Girls
9. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
10. NicOx Provides an Update on the Phase 2a Study for NCX 1000 Conducted With Axcan
11. Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
Post Your Comments:
(Date:4/27/2015)... April 27, 2015  Eiger BioPharmaceuticals, Incorporated today announced ... of lonafarnib in patients with chronic hepatitis delta viral ... program, enrolled at Ankara University Medical School, ... endemic. LOWR HDV - 1 (LOnafarnib ... study which randomized subjects to receive different doses of ...
(Date:4/27/2015)... 27, 2015 Kalorama Information expects the ... (EMR) to grow well past the period where ... to a recent report.  The healthcare market research ... continued efficiency improvements will grow the market seven ... five years.  The market for EMR systems continues ...
(Date:4/27/2015)... 2015  Novira Therapeutics, Inc., a privately held, clinical-stage ... chronic hepatitis B virus (HBV) infection, today announced the ... core inhibitor candidate, NVR 3-778, at the 2015 annual ... the Liver (EASL) in Vienna, Austria ... from studies performed in a humanized UPA/SCID mouse model ...
Breaking Medicine Technology:Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3Kalorama: EMR Market Expected To Grow Beyond Incentives 2Kalorama: EMR Market Expected To Grow Beyond Incentives 3Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 2Novira Therapeutics Announces Presentation of Preclinical Antiviral Data for NVR 3-778 at EASL 3
... 17, 2011 Damage to the spine can happen for ... car accident, wear and tear from old age, or blunt ... past have had to deal with back braces, reduced mobility, ... Seyed M. Rezaian,s patented Spinal Fixator, patients are able to ...
... Unilife Corporation ("Unilife" or the "Company") (NASDAQ: ... Deputy Secretary of the U.S. Department of Agriculture, for a ... at its facility in York, Pennsylvania. The White ... direction of President Obama. The Winning the Future Roundtables ...
Cached Medicine Technology:Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine 2Unilife Hosts White House Business Council Meeting 2Unilife Hosts White House Business Council Meeting 3
(Date:4/27/2015)... 27, 2015 Women may have a ... according to a new study published online in the ... brain injury (MTBI), is a common medical problem affecting ... , In most cases, patients who experience MTBI ... 15 percent of MTBI patients will continue to experience ...
(Date:4/27/2015)... Moreno Ranches, a producer of Brahman ... to announce their "This is It" educational Brahman cattle ... breeding and education was a huge success. The educational ... 2015. It brought together youth, educators, and experts ... breeding in general, and Brahman cattle breeding in particular. ...
(Date:4/27/2015)... April 27, 2015 UC Davis ... molecular basis of an inherited disorder that historically ... also arises in other populations of Semitic descent, ... series of elegant experiments, the researchers uncovered the ... leukodystrophy that is an incurable and progressively fatal ...
(Date:4/27/2015)... April 27, 2015 On May 5, people ... ask their social media friends around the world to join ... asthma. , May 5 is World Pulmonary Hypertension Day ... leader in the global PH community, will take part in ... blood pressure of the lungs. PH is an increase in ...
(Date:4/27/2015)... Array Health , a leading provider ... Lance Hood, senior director of marketing, will participate in ... Health Care Marketing Summit on April 29, 2015. ... Director of Payer Services, Leavitt Partners, LLC, will address ... a retail/e-commerce perspective – and equip attendees with the ...
Breaking Medicine News(10 mins):Health News:Women Show Persistent Memory Impairment after Concussion 2Health News:Women Show Persistent Memory Impairment after Concussion 3Health News:Leading Ranch for Brahman Cattle for Sale, Moreno Ranches, Announces Conclusion of 'This is It' Event for Brahman Juniors. 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 2Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 3Health News:UC Davis Makes Breakthrough in Understanding Canavan Disease 4Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 2Health News:Pulmonary Hypertension Association Marks World PH Day on May 5 with a Worldwide Lifesaving Social Media Blitz 3Health News:Array Health’s Senior Director of Marketing to Present at The Fourth Annual Direct-to-Consumer Health Care Marketing Summit 2
... life when some students pushed him from the front bench in ... ,Qamar Irfan, a Class 5 student of Sarda Convent School in ... forcibly pushed off the bench by students in a fight over ... members, Qamar rushed into the class as soon as school opened ...
... diagnosed with stomach cancer. He was 68 years old then.// ... out that the hospital pathologist had misdiagnosed tests and Mr. ... out in October 2002 at Walsall Manor Hospital. The pathologist ... Wolverhampton trust. Royal Wolverhampton Hospitals NHS Trust owned up liability ...
... who are circumcised are less likely to contract HIV ... research presented recently at the International AIDS Conference at ... percent less likely to contract HIV than their uncircumcised ... ,Circumcision is the surgical removal of the foreskin ...
... New York shows that patients, who experience the health ... //be a lot done for its improvement, with almost ... health care. ,According to the ... Performance Health System, an astonishingly high amount of Americans, ...
... According to a new study by Duke University Medical ... the rate of treatment //for chronic hepatitis C than ... in the August issue of Gastroenterology, which is the ... (AGA), that the African American patients with hepatitis C ...
... The Health Service Executive in Ireland is all set to ... emergency overcrowding.// ,The Irish Examiner reports that hospitals may ... with the A&E crisis, where patients are made to wait ... A&E patients are not made to wait over 24 hours. ...
Cached Medicine News:Health News:Majority Of People In US Seek Essential Changes In Health Care System 2Health News:Majority Of People In US Seek Essential Changes In Health Care System 3Health News:Majority Of People In US Seek Essential Changes In Health Care System 4Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 2Health News:African-Americans Have A Reduced Response To Hepatitis C Treatment 3
IFA for the direct detection of Respiratory Syncytial Virus (RSV)...
... RSV Test utilizes a new, improved format that ... rapid RSV detection. The testing device employs innovative ... reagents have already been applied to the testing ... with clear-cut results shown by the appearance of ...
Latex agglutination slide test for the qualitative detection of rotavirus from fecal specimens....
ELISA for Anti-Proteinase 3 PR3 (cANCA)....
Medicine Products: